B16-OVA tumor model

XX Xiaoping Xie
LZ Lele Zhu
ZJ Zuliang Jie
YL Yanchuan Li
MG Meidi Gu
XZ Xiaofei Zhou
HW Hui Wang
JC Jae-Hoon Chang
CK Chun-Jung Ko
XC Xuhong Cheng
SS Shao-Cong Sun
request Request a Protocol
ask Ask a question
Favorite

Traf2-TKO mice and age- and sex-matched wild-type control mice (6–8 weeks old) were infected with a low dose (1 × 104 cfu/mouse) of LM-OVA on day 0. After 40 days, mice were injected s.c. with 8 × 105 B16-OVA murine melanoma cells and monitored for tumor growth and survival. Mice with tumor volumes measuring 225 mm2 were considered moribund and sacrificed according to protocols approved by the Institutional Animal Care and Use Committee of the University of Texas MD Anderson Cancer Center.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A